GLP-1 medications may affect more than appetite and weight loss. Many patients report psychological changes such as reduced cravings, altered reward responses, shifts in mood, and changes in emotional eating behaviors. In this article, we explore the potential mental health benefits and risks of GLP-1 medications, helping patients better understand how these treatments may influence both the body and the mind.

GLP-1 medications like semaglutide and tirzepatide can be powerful tools for weight loss and metabolic health—but the surge in demand has created a “Wild West” of unvetted products, online clinics, and compounded formulas. Patients must understand the risks of counterfeit drugs, improper dosing, and lack of medical oversight before starting therapy.